Home / Health / EU negotiating with drugmakers to secure potential Covid-19 vaccines

EU negotiating with drugmakers to secure potential Covid-19 vaccines

The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential Covid-19 vaccine

covid, coronavirus, vaccine, drug, pharma

Premium

The multiple talks confirm the bloc's more assertive stance on procuring potential Covid-19 shots and drugs after early US moves in securing promising treatments and vaccines

Reuters Brussels

4 min read Last Updated : Jul 18 2020 | 1:00 AM IST

The European Union is negotiating advance purchase deals of potential Covid-19 vaccines with drugmakers Moderna, Sanofi and Johnson & Johnson as well as biotech firms BioNtech and CureVac, two EU sources told Reuters.

The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential Covid-19 vaccine, in principle available to all 27 EU nations.

The information on the ongoing talks was shared by the European Commission, the EU executive arm, with EU health ministers at a meeting in Berlin on Thursday, the sources said.

The

Topics : Coronavirus Lockdown Community Transmission Coronavirus Vaccine European Union Coronavirus Tests Johnson and Johnson

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in